The prevalence of treatable left ventricular systolic dysfunction in patients who present with noncardiac vascular episodes
| Autor: | Allan D. Struthers, Peter A. Stonebridge, Hugh Tunstall-Pedoe, Ron MacWalter, Anthony Staines, Robert V. Kelly |
|---|---|
| Rok vydání: | 2002 |
| Předmět: |
medicine.medical_specialty
Ejection fraction medicine.diagnostic_test Vascular disease business.industry Case-control study medicine.disease Asymptomatic Sudden cardiac death Peripheral Internal medicine medicine Cardiology cardiovascular diseases medicine.symptom business Cardiology and Cardiovascular Medicine Stroke Electrocardiography |
| Zdroj: | Journal of the American College of Cardiology. 39(2):219-224 |
| ISSN: | 0735-1097 |
| DOI: | 10.1016/s0735-1097(01)01725-9 |
| Popis: | Objectives We sought to determine the prevalence of treatable left ventricular (LV) systolic dysfunction (LVSD) in patients who present with their first noncardiac vascular episode. Background Screening for LV dysfunction in patients who present with their first stroke (cerebrovascular accident), their first transient ischemic attack (TIA) or their first manifestation of peripheral vascular disease (PVD) may represent a golden opportunity to identify treatable LV dysfunction, and so their known high incidence of sudden cardiac death may be reduced. Methods Participating in this study were 522 (75%) of 700 consecutive patients (302 patients with stroke, TIA or PVD and 220 age- and gender-matched control subjects). Each underwent a full clinical assessment, 12-lead electrocardiography and two-dimensional echocardiography. Left ventricular dysfunction was defined as LV ejection fraction ≤40%. Results Seventy-two (28%) patients with vascular disease and 11 (5.5%) control subjects were found to have LVSD. Twenty-six (28%) stroke patients, 22 (26%) patients with TIA and 24 (31%) patients with PVD had LVSD. Left ventricular systolic dysfunction was symptomatic in 44% of patients and in 35% of control subjects. Conclusions Left ventricular systolic dysfunction is five times more common among patients with stroke, TIA and PVD than among age- and gender-matched control subjects. Asymptomatic LVSD is more common than symptomatic LVSD in these patients. These findings suggest that routine screening of all patients with noncardiac vascular episodes for LVSD should now be considered. Future studies should investigate whether identifying and treating LVSD in these patients would reduce their known high rate of cardiac death. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|